NASDAQ · CCIXW

Churchill Capital Corp. IX

$0.00 -$0.01 (-55.00%) 1D Market open

Key Metrics

Market cap
P/E · TTM
Revenue · TTM
$7.34M
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y 1.51
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jul 1 high, the share price fell 100%.

    Peak close $0.90 on Jul 1; trough close $0.00 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -100%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 15
    The stock moved -98.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 15
  • Jun 24
    The stock moved +77.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.00 – $1.70
Avg volume · 20D49.1K
Net cash
Book value / share
IndustryServices-Computer Integrated Systems Design
ExchangeNASDAQ
About Churchill Capital Corp. IX
IPO dateJun 21, 2024
Employees

Churchill Capital Corp IX is a special purpose acquisition company.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -79.9% · —

Financial Health

Current ratio0.30
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital−$664.40K

Cash Flow · TTM

Operating CF −$3.55M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings